Precise Biometrics announces outcome of exercise period for warrants of series 2026 (TO2)

AI SummaryClose X

Precise Biometrics AB announced the outcome of its warrant exercise period for series 2026 (TO2), with 1,151,234,990 warrants exercised, representing approximately 62 percent of the total issued warrants. This exercise will result in the company receiving approximately SEK 2.6 million before issue costs, through the subscription of 5,456,090 new shares at SEK 0.47 per share. Consequently, the company's share capital will increase by SEK 1,636,827, and the total number of shares will rise to 274,143,719.

Disclaimer*

UK 100

Latest directors dealings